Vanda Pharmaceuticals VNDA
NASDAQ VNDA
$5.03 -0.14 (-2.71%)
At close: Sep 29, 2026 · 4:00 PM EDT

Vanda Pharmaceuticals (VNDA) EBT Margin (2010 - 2026)

Updated

Vanda Pharmaceuticals (VNDA) posted EBT Margin of -123.46% for Q2 2026, down 57.12 percentage points from -66.34% a year earlier and down 29.83 percentage points from the prior quarter.

Analysis

Vanda Pharmaceuticals (VNDA) EBT Margin (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBT Margin at Vanda Pharmaceuticals was -82.14%, down 40.37 percentage points year-over-year; for FY2025, it was -64.16%, down 52.63 percentage points from FY2024.

  • Annual EBT Margin has declined for four consecutive years, with a five-year change of -76.91 percentage points (FY2020 to FY2025).
  • In prior years, Vanda Pharmaceuticals' EBT Margin was -11.53% in FY2024 (-14.82 pp), 3.29% in FY2023 (-1.15 pp), 4.44% in FY2022 (-11.33 pp) and 15.77% in FY2021 (+3.01 pp).
  • The Q2 2026 figure stands as the lowest quarterly EBT Margin since Q2 2014.
  • On a year-over-year basis, EBT Margin has declined in each of the last 13 quarters, with an average year-over-year change of -38.66 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for EBT Margin in the past five years was Q1 2023, with a gain of 21.41 percentage points; the weakest was Q1 2025, with a drop of 64.85 percentage points.
  • According to Business Quant data, EBT Margin for the three prior quarters was -93.63% (Q1 2026), -66.42% (Q4 2025) and -50.46% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 Vanda Pharmaceuticals 312.55 Mn -617.39 Mn 46.97 Mn -123.46%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -123.46%
Mar 31, 2026 -93.63%
Dec 31, 2025 -66.42%
Sep 30, 2025 -50.46%
Jun 30, 2025 -66.34%
Mar 31, 2025 -74.67%
Dec 31, 2024 -12.22%
Sep 30, 2024 -13.10%
Jun 30, 2024 -10.93%
Mar 31, 2024 -9.83%
Dec 31, 2023 -3.67%
Sep 30, 2023 -0.31%
Jun 30, 2023 5.63%
Mar 31, 2023 8.85%
Dec 31, 2022 14.91%
Sep 30, 2022 8.36%
Jun 30, 2022 5.89%
Mar 31, 2022 -12.57%
Dec 31, 2021 12.66%
Sep 30, 2021 15.30%
API Access

Vanda Pharmaceuticals EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=VNDA&period=max&api_key=YOUR_API_KEY